| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | 2MK663C346 |
| InChI Key | IDXCXSCCZNCXCL-XMADEQCMSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C49H75N15O12S |
| Molecular Weight | 1098.3 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Bradykinin B2 receptor agonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Bradykinin receptor
|
- | - | - | 19 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Medulloblastoma | 1 | D008527 | ClinicalTrials |
| Meningitis, Cryptococcal | 1 | D016919 | ClinicalTrials |
| Glioma | 1 | D005910 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2105864 |
| DrugBank | DB06549 |
| FDA SRS | 2MK663C346 |
| Guide to Pharmacology | 672 |
| PubChem | 6918284 |
| SureChEMBL | SCHEMBL411837 |